AdvaMed® Position Statement Regarding Transition to National Reimbursement Codes
This AdvaMed® position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.
Coverage & Payment
Learn more about our Payment & Health Care Delivery Policy work.
Regulations and Reimbursement of Software as a Medical Device in Europe- Part1
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
A Framework for Comprehensive Assessment of Medical Technologies
AdvaMed® launched a Strategic Value Initiative to develop principles and an approach for assessing the value of medical technologies that can be adopted by medtech companies, health systems, payers, and…
A Framework for Comprehensive Assessment of the Value of Diagnostic Tests
It is critical for diagnostic test developers to demonstrate the value of their tests to a variety of stakeholders. This framework serves as a resource for members to assess and…
AdvaMed®’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
Medtech POV Podcast: Titan Medical’s Cary Vance Talks Robotic Innovation in Medtech, the Importance of MDUFA V, and Addressing Supply Chain Issues
Cary Vance, President and CEO of Titan Medical, joined AdvaMed®’s Scott Whitaker on the Medtech POV podcast to share his experience leading a small medical device company through the regulatory…
Easing Disparities for Patients via Smart Technology, Equally Smart Policies
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
AdvaMed® Submits Comments on CY 2023 OPPS/ASC Proposed Rule
AdvaMed® submitted comments to CMS on the CY 2023 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule.
AdvaMed® Submits Comments on the CY 2023 PFS Proposed Rule
AdvaMed® submitted comments to CMS on the Calendar Year 2023 Physician Fee Schedule (PFS) proposed rule.
AdvaMed® Responds to CMS’ Request for Information Regarding Medicare Advantage
AdvaMed® submitted a letter to CMS’s RFI on Medicare regarding ways to strengthen the Medicare Advantage program to align with the Vision for Medicare and CMS’ Strategic Pillars.